Botox Cosmetic FDA Approval History
FDA Approved: Yes (First approved April 12, 2002)
Brand name: Botox Cosmetic
Generic name: onabotulinumtoxinA
Dosage form: for Injection
Company: AbbVie Inc.
Treatment for: Facial Wrinkles, Glabellar Lines, Platysma Bands
Botox Cosmetic (onabotulinumtoxinA) is an acetylcholine release inhibitor and a neuromuscular blocking agent used for temporary improvement in the appearance of glabellar lines, lateral canthal lines, forehead lines, and platysma bands.
- Botox Cosmetic is indicated in adult patients for the temporary improvement in the appearance of:
• Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
• Moderate to severe lateral canthal lines associated with orbicularis oculi activity
• Moderate to severe forehead lines associated with frontalis muscle activity
• Moderate to severe platysma bands associated with platysma muscle activity.
Development timeline for Botox Cosmetic
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.